Tick-borne diseases of the USA: Ten things clinicians should know

Journal of Infection

Volumn 71, Issue S1, 2015, Pages S88-S96

  Buckingham, Steven C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Anaplasmosis; Babesiosis; DEET; Doxycycline; Ehrlichiosis; Lyme disease; Rocky mountain spotted fever; Tick borne diseases; Tularemia

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CHLORAMPHENICOL; CLINDAMYCIN; DIETHYLTOLUAMIDE; DOXYCYCLINE; INSECT REPELLENT; PERMETHRIN; QUININE; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; EHRLICHIOSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; LABORATORY DIAGNOSIS; LYME DISEASE; NONHUMAN; PIROPLASMOSIS; POPULATION RESEARCH; PROGNOSIS; PROTECTIVE CLOTHING; SEASONAL VARIATION; TICK BITE; TICK BORNE DISEASE; TOOTH DISCOLORATION; TREATMENT INDICATION; UNITED STATES; WINTER; EPIDEMIOLOGY;

HUMANS; TICK-BORNE DISEASES; UNITED STATES;

EID: 84930637948     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.04.009     Document Type: Article

References (40)

1. Chapman A.S., Bakken J.S., Folk S.M., Paddock C.D., Bloch K.C., Krusell A., et al. Diagnosis and management of tick-borne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States. Morb Mortal Wkly Rep 2006, 55(RR-4):1-28.
2. Salgo M.P., Telzak E.E., Currie B., Perlman D.C., Litman N., Levi M., et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med 1988, 318(21):1345-1348.
3. Buckingham S.C., Marshall G.S., Schutze G.E., Woods C.R., Jackson M.A., Patterson L.E., et al. Clinical and laboratory features of Rocky Mountain spotted fever in children. J Pediatr 2007, 150(2):180-184.
4. Marshall G.S., Stout G.G., Jacobs R.F., Schutze G.E., Paxton H., Buckingham S.C., et al. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med 2003, 157(5):443-448.
5. Marshall G.S., Jacobs R.F., Schutze G.E., Paxton H., Buckingham S.C., DeVincenzo J.P., et al. Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States. Arch Pediatr Adolesc Med 2002, 156(2):166-170.
6. American Academy of Pediatrics Lyme disease. Red Book: 2012 report of the Committee on Infectious Diseases 2012, 474-479. American Academy of Pediatrics, Elk Grove Village, IL. 29th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
7. Campbell G.L., Paul W.S., Schriefer M.E., Craven R.B., Robbins K.E., Dennis D.T. Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri, 1990-1993. J Infect Dis 1995, 172(2):470-480.
8. James A.M., Liveris D., Wormser G.P., Schwartz I., Montecalvo M.A., Johnson B.J. Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis 2001, 183(12):1810-1814.
9. Masters E.J., Grigery C.N., Masters R.W. STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness. Infect Dis Clin North Am 2008, 22(2):361-376.
10. Schutze G.E., Buckingham S.C., Marshall G.S., Woods C.R., Jackson M.A., Patterson L.E., et al. Human monocytic ehrlichiosis in children. Pediatr Infect Dis J 2007, 26(6):475-479.
11. Harrell G.T. Rocky Mountain spotted fever. Medicine 1949, 28:333-370.
12. Chapman A.S., Murphy S.M., Demma L.J., Holman R.C., Curns A.T., McQuiston J.H., et al. Rocky Mountain spotted fever in the United States, 1997-2002. Vector Borne Zoonotic Dis 2006, 6(2):170-178.
13. Dalton M.J., Clarke M.J., Holman R.C., Krebs J.W., Fishbein D.B., Olson J.G., et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995, 52(5):405-413.
14. Treadwell T.A., Holman R.C., Clarke M.J., Krebs J.W., Paddock C.D., Childs J.E. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 2000, 63(1-2):21-26.
15. Bradford W.D., Hawkins H.K. Rocky Mountain spotted fever in childhood. Am J Dis Child 1977, 131(11):1228-1232.
16. Helmick C.G., Bernard K.W., D'Angelo L.J. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984, 150(4):480-488.
17. Woods C.R. Rocky Mountain spotted fever in children. Pediatr Clin North Am 2013, 60(2):455-470.
18. Hattwick M.A.W., Retailliau H., O'Brien R.J., Slutzker M., Fontaine R.E., Hanson B. Fatal Rocky Mountain spotted fever. JAMA 1978, 240(14):1499-1503.
19. Buckingham S.C. Tick-borne diseases in children: epidemiology, clinical manifestations and optimal treatment strategies. Paediatr Drugs 2005, 7(3):163-176.
20. Kirkland K.B., Wilkinson W.E., Sexton D.J. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995, 20(5):1118-1121.
21. Dahlgren F.S., Holman R.C., Paddock C.D., Callinan L.S., McQuiston J.H. Fatal Rocky Mountain spotted fever in the United States, 1999-2007. Am J Trop Med Hyg 2012, 86(4):713-719.
22. Hamburg B.J., Storch G.A., Micek S.T., Kollef M.H. The importance of early treatment with doxycycline in human ehrlichiosis. Medicine 2008, 87(2):53-60.
23. American Academy of Pediatrics Rocky Mountain spotted fever. Red Book: 2012 report of the Committee on Infectious Diseases 2012, 623-625. American Academy of Pediatrics, Elk Grove Village, IL. 29th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
24. Holman R.C., Paddock C.D., Curns A.T., Krebs J.W., McQuiston J.H., Childs J.E. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001, 184(11):1437-1444.
25. American Academy of Pediatrics Ehrlichia and Anaplasma infections. Red Book: 2012 report of the Committee on Infectious Diseases 2012, 312-315. American Academy of Pediatrics, Elk Grove Village, IL. 29th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
26. Abramson J.S., Givner L.B. Should tetracycline be contraindicated for therapy of presumed Rocky Mountain spotted fever in children less than 9 years of age?. Pediatrics 1990, 86(1):123-124.
27. Smith M., Unkel J.H., Fenton S.J., DeVincenzo J.P. The use of tetracyclines in pediatric patients. J Pediatr Pharmacol Ther 2001, 6:66-71.
28. Forti G., Benincori C. Doxycycline and the teeth. Lancet 1969, 1(7598):782-783.
29. Lochary M.E., Lockhart P.B., Williams W.T. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998, 17(5):429-431.
30. Volovitz B., Shkap R., Amir J., Calderon S., Varsano I., Nussinovitch M. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr 2007, 46(2):121-126.
31. Wormser G.P., Dattwyler R.J., Shapiro E.D., Halperin J.J., Steere A.C., Klempner M.S., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43(9):1089-1134.
32. Skogman B.H., Croner S., Nordwall M., Eknefelt M., Ernerudh J., Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J 2008, 27(12):1089-1094.
33. Lantos P.M., Charini W.A., Medoff G., Moro M.H., Mushatt D.M., Parsonnet J., et al. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis 2010, 51(1):1-5.
34. Feder H.M., Johnson B.J., O'Connell S., Shapiro E.D., Steere A.C., Wormser G.P. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007, 357(14):1422-1430.
35. Halperin J.J., Baker P., Wormser G.P. Common misconceptions about Lyme disease. Am J Med 2013, 126(3):264.e1-264.e7.
36. American Academy of Pediatrics Prevention of tick-borne infections. Red Book: 2012 report of the Committee on Infectious Diseases 2012, 207-209. American Academy of Pediatrics, Elk Grove Village, IL. 29th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
37. Needham G.R. Evaluation of five popular methods for tick removal. Pediatrics 1985, 75(6):997-1002.
38. Fradin M.S., Day J.F. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002, 347(1):13-18.
39. Environmental Protection Agency web site. DEET. 2014 review. [accessed 11.10.14]. http://www.epa.gov/pesticides/factsheets/chemicals/deet.htm?src=QHA099.
40. American Academy of Pediatrics Prevention of mosquitoborne infections. Red Book: 2012 report of the Committee on Infectious Diseases 2012, 209-211. American Academy of Pediatrics, Elk Grove Village, IL. 29th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).